|
Name |
Questin
|
Molecular Formula | C16H12O5 | |
IUPAC Name* |
1,6-dihydroxy-8-methoxy-3-methylanthracene-9,10-dione
|
|
SMILES |
CC1=CC2=C(C(=C1)O)C(=O)C3=C(C2=O)C=C(C=C3OC)O
|
|
InChI |
InChI=1S/C16H12O5/c1-7-3-9-13(11(18)4-7)16(20)14-10(15(9)19)5-8(17)6-12(14)21-2/h3-6,17-18H,1-2H3
|
|
InChIKey |
UUNPIWCQMVNINR-UHFFFAOYSA-N
|
|
Synonyms |
Questin; 3774-64-9; 1,6-dihydroxy-8-methoxy-3-methylanthracene-9,10-dione; Emodin-8-methyl ether; CHEBI:16200; 7Z6321X03I; 9,10-Anthracenedione,1,6-dihydroxy-8-methoxy-3-methyl-; 1,6-dihydroxy-8-methoxy-3-methylanthraquinone; 1,6-dihydroxy-8-methoxy-3-methyl-9,10-anthraquinone; 3,8-dihydroxy-1-methoxy-6-methylanthracene-9,10-dione; 1,6-dihydroxy-3-methyl-8-(methyloxy)anthracene-9,10-dione; UNII-7Z6321X03I; 9,10-Anthracenedione, 1,6-dihydroxy-8-methoxy-3-methyl-; Emodin 8-O-methylether; Questin_120240; CHEMBL453315; SCHEMBL15676283; DTXSID30191177; HY-137990; CS-0143542; C01448; 1,6-Dihydroxy-8-methoxy-3-methyl-anthraquinone; Q27098581; 1,6-dihydroxy-8-methoxy-3-methyl-anthracene-9,10-dione
|
|
CAS | 3774-64-9 | |
PubChem CID | 160717 | |
ChEMBL ID | CHEMBL453315 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 284.26 | ALogp: | 3.0 |
HBD: | 2 | HBA: | 5 |
Rotatable Bonds: | 1 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 83.8 | Aromatic Rings: | 3 |
Heavy Atoms: | 21 | QED Weighted: | 0.717 |
Caco-2 Permeability: | -5.004 | MDCK Permeability: | 0.00001520 |
Pgp-inhibitor: | 0.022 | Pgp-substrate: | 0.008 |
Human Intestinal Absorption (HIA): | 0.028 | 20% Bioavailability (F20%): | 0.07 |
30% Bioavailability (F30%): | 0.993 |
Blood-Brain-Barrier Penetration (BBB): | 0.064 | Plasma Protein Binding (PPB): | 97.26% |
Volume Distribution (VD): | 0.49 | Fu: | 1.90% |
CYP1A2-inhibitor: | 0.951 | CYP1A2-substrate: | 0.847 |
CYP2C19-inhibitor: | 0.145 | CYP2C19-substrate: | 0.063 |
CYP2C9-inhibitor: | 0.565 | CYP2C9-substrate: | 0.65 |
CYP2D6-inhibitor: | 0.393 | CYP2D6-substrate: | 0.271 |
CYP3A4-inhibitor: | 0.684 | CYP3A4-substrate: | 0.16 |
Clearance (CL): | 10.931 | Half-life (T1/2): | 0.315 |
hERG Blockers: | 0.032 | Human Hepatotoxicity (H-HT): | 0.052 |
Drug-inuced Liver Injury (DILI): | 0.915 | AMES Toxicity: | 0.814 |
Rat Oral Acute Toxicity: | 0.189 | Maximum Recommended Daily Dose: | 0.925 |
Skin Sensitization: | 0.208 | Carcinogencity: | 0.263 |
Eye Corrosion: | 0.004 | Eye Irritation: | 0.961 |
Respiratory Toxicity: | 0.104 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC002031 | 0.932 | D07MGA | 0.372 | ||||
ENC000913 | 0.773 | D0N1FS | 0.354 | ||||
ENC000094 | 0.762 | D06GCK | 0.326 | ||||
ENC000362 | 0.754 | D04AIT | 0.292 | ||||
ENC005602 | 0.746 | D0AZ8C | 0.292 | ||||
ENC001971 | 0.746 | D0K8KX | 0.286 | ||||
ENC005489 | 0.718 | D01XWG | 0.280 | ||||
ENC003915 | 0.712 | D07VLY | 0.273 | ||||
ENC002107 | 0.706 | D0C9XJ | 0.273 | ||||
ENC005490 | 0.700 | D01XDL | 0.250 |